Category
GLP-1 & Metabolic Health Peptides
GLP-1 receptor agonists and related incretin/amylin-pathway compounds are studied for glycemic control, appetite regulation, and fat loss. This hub covers the individual compounds, their mechanism of action, and the stacks built around them.
31 compounds in this category
Peptide
Albiglutide
Albiglutide is used or studied for glucose control and related fat loss and metabolic health goals. Potential benefits and safety depend on indication, formulation, dose, and medical supervision.
Peptide
AOD-9604
AOD-9604 is used or studied for may promote fat loss and related fat loss and metabolic health goals. Potential benefits and safety depend on indication, formulation, dose, and medical supervision.
Peptide Stack
AOD-9604 + L-carnitine stack
A clinic fat-loss support stack combining a GH fragment with carnitine-based mitochondrial and fat-oxidation support.
Peptide Stack
AOD-9604 regimen
A fat-loss peptide regimen marketed to support lipolysis and body-composition goals, with limited clinical support.
Peptide
Cagrilintide
Cagrilintide is used or studied for appetite suppression and related fat loss and metabolic health goals. Potential benefits and safety depend on indication, formulation, dose, and medical supervision.
Peptide Stack
CagriSema
An investigational obesity stack combining GLP-1 and amylin-pathway appetite control.
Vitamin
Cyanocobalamin or methylcobalamin injection
A vitamin B12 injection used for deficiency treatment and commonly marketed for energy support in wellness clinics.
Peptide
Dulaglutide
Dulaglutide is used or studied for glycemic control and related fat loss and metabolic health goals. Potential benefits and safety depend on indication, formulation, dose, and medical supervision.
Peptide
Exenatide
Exenatide is used or studied for glycemic control; weight loss and related fat loss and metabolic health goals. Potential benefits and safety depend on indication, formulation, dose, and medical supervision.
Peptide Stack
GLP-1 + metformin stack
A metabolic stack used to combine appetite control with insulin-sensitivity support.
Peptide Stack
GLP-1 + pramlintide stack
A satiety-focused metabolic stack intended to enhance appetite control and meal-related glucose management.
Amino Acid Derivative
Levocarnitine adjunct
A carnitine-based support compound used for deficiency treatment and marketed for mitochondrial and fat-oxidation support.
Peptide
Liraglutide
Liraglutide is used or studied for weight loss; glucose control and related fat loss and metabolic health goals. Potential benefits and safety depend on indication, formulation, dose, and medical supervision.
Peptide Stack
Liraglutide anchor regimen
A daily GLP-1 weight-management anchor used for appetite reduction and metabolic health support.
Small Molecule Drug
Metformin
A prescription metabolic medication used to improve insulin sensitivity and blood sugar control.
Peptide
Metreleptin
Metreleptin is used or studied for treats leptin deficiency and related fat loss and metabolic health goals. Potential benefits and safety depend on indication, formulation, dose, and medical supervision.
Vitamin Blend
MIC + B12 injection
A lipotropic clinic injection marketed to support energy, weight-management programs, and liver-related nutrient support.
Peptide
Peptide YY (PYY)
Peptide YY (PYY) is used or studied for reduces appetite and related fat loss and metabolic health goals. Potential benefits and safety depend on indication, formulation, dose, and medical supervision.
Peptide
Pramlintide
Pramlintide is used or studied for reduces appetite; slows gastric emptying and related fat loss and metabolic health goals. Potential benefits and safety depend on indication, formulation, dose, and medical supervision.
Peptide
Retatrutide
Retatrutide is used or studied for extreme weight loss (trials) and related fat loss and metabolic health goals. Potential benefits and safety depend on indication, formulation, dose, and medical supervision.
Peptide
Semaglutide
Semaglutide is used or studied for weight loss; glycemic control and related fat loss and metabolic health goals. Potential benefits and safety depend on indication, formulation, dose, and medical supervision.
Peptide Blend
Semaglutide + B12 blend
A compounded clinic blend marketed for weight loss with added B12-based energy support.
Peptide Stack
Semaglutide anchor regimen
A prescription GLP-1 weight-management anchor used to reduce appetite, improve glucose control, and support long-term fat loss.
Peptide
Setmelanotide
Setmelanotide is used or studied for treats genetic obesity and related fat loss and metabolic health goals. Potential benefits and safety depend on indication, formulation, dose, and medical supervision.
Peptide
Tesamorelin
Tesamorelin is a synthetic growth hormone-releasing factor analog used to reduce excess abdominal visceral fat in HIV-infected adults with lipodystrophy. It is given by subcutaneous injection and is not indicated for general weight loss; notable risks include fluid retention, glucose intolerance, elevated IGF-1, and injection-site reactions.
Peptide Stack
Tesamorelin anchor regimen
A visceral-fat reduction regimen approved for HIV-associated lipodystrophy and sometimes discussed in body-composition programs.
Small Molecule Drug
Tesofensine
Tesofensine is used or studied for weight loss; appetite suppression and related fat loss and metabolic health goals. Potential benefits and safety depend on indication, formulation, dose, and medical supervision.
Peptide
Tirzepatide
Tirzepatide is used or studied for significant weight loss; glucose control and related fat loss and metabolic health goals. Potential benefits and safety depend on indication, formulation, dose, and medical supervision.
Peptide Blend
Tirzepatide + B12 blend
A compounded clinic blend marketed for weight loss with added B12-based energy support.
Peptide Stack
Tirzepatide anchor regimen
A prescription weight-management anchor used to reduce appetite, improve blood sugar control, and support sustained fat loss.
Hormone Stack
TRT + GLP-1 stack
A body-composition and metabolic-health stack used when weight management overlaps with confirmed low-testosterone care.
Frequently asked questions
What do GLP-1 peptides do?
GLP-1 receptor agonists mimic the incretin hormone GLP-1, slowing gastric emptying, increasing insulin secretion in response to meals, and reducing appetite. This combination is why they are studied for both glycemic control and weight management.
Are GLP-1 peptides FDA approved?
Several GLP-1 compounds (such as semaglutide and tirzepatide) have FDA-approved formulations for diabetes or weight management, while others in this category are earlier-stage or used off-label. Check each compound profile’s regulatory status before assuming approval.
Other categories